Literature DB >> 12457776

Recent advances in angiogenesis, anti-angiogenesis and vascular targeting.

Andreas Bikfalvi1, Roy Bicknell.   

Abstract

Angiogenesis, the development of new blood vessels, has become a major focus of research. This has been stimulated by the therapeutic opportunities offered by the ability to manipulate the vasculature in pathologies such as cancer. Here, we present an overview of recent advances in angiogenesis. Especially noteworthy is the large volume of information from developmental studies, particularly those that involve transgenic and gene knockout mice. We also discuss the increasing repertoire of drugs with which to manipulate angiogenesis and new endothelial-specific genes with which to target the vasculature.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12457776     DOI: 10.1016/s0165-6147(02)02109-0

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  32 in total

1.  Synthesis of ribozyme against vascular endothelial growth factor165 and its biological activity in vitro.

Authors:  Zhong-Ping Gu; Yun-Jie Wang; Yu Wu; Jin-Ge Li; Nong-An Chen
Journal:  World J Gastroenterol       Date:  2004-05-15       Impact factor: 5.742

2.  Negative regulation of HIF-1α by an FBW7-mediated degradation pathway during hypoxia.

Authors:  Jessica M Cassavaugh; Sarah A Hale; Theresa L Wellman; Alan K Howe; Cheung Wong; Karen M Lounsbury
Journal:  J Cell Biochem       Date:  2011-12       Impact factor: 4.429

Review 3.  Drug carrier interaction with blood: a critical aspect for high-efficient vascular-targeted drug delivery systems.

Authors:  Daniel J Sobczynski; Margaret B Fish; Catherine A Fromen; Mariana Carasco-Teja; Rhima M Coleman; Omolola Eniola-Adefeso
Journal:  Ther Deliv       Date:  2015-08-14

4.  Twist overexpression induces in vivo angiogenesis and correlates with chromosomal instability in breast cancer.

Authors:  Yelena Mironchik; Paul T Winnard; Farhad Vesuna; Yoshinori Kato; Flonne Wildes; Arvind P Pathak; Scott Kominsky; Dmitri Artemov; Zaver Bhujwalla; Paul Van Diest; Horst Burger; Carlotta Glackin; Venu Raman
Journal:  Cancer Res       Date:  2005-12-01       Impact factor: 12.701

5.  Regulation of ocular angiogenesis by Notch signaling: implications in neovascular age-related macular degeneration.

Authors:  Iqbal Ahmad; Sudha Balasubramanian; Carolina B Del Debbio; Sowmya Parameswaran; Allen R Katz; Carol Toris; Robert N Fariss
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-05-02       Impact factor: 4.799

6.  Alphastatin downregulates vascular endothelial cells sphingosine kinase activity and suppresses tumor growth in nude mice bearing human gastric cancer xenografts.

Authors:  Lin Chen; Tao Li; Rong Li; Bo Wei; Zheng Peng
Journal:  World J Gastroenterol       Date:  2006-07-14       Impact factor: 5.742

Review 7.  Tumour angiogenesis: the relevance to surgeons.

Authors:  G K Atkin; A Chopada
Journal:  Ann R Coll Surg Engl       Date:  2006-10       Impact factor: 1.891

8.  Design, synthesis, and evaluation of original carriers for targeting vascular endothelial growth factor receptor interactions.

Authors:  Mario Gonçalves; Karine Estieu-Gionnet; Thomas Berthelot; Georges Laïn; Mireille Bayle; Xavier Canron; Natacha Betz; Andreas Bikfalvi; Gérard Déléris
Journal:  Pharm Res       Date:  2005-08-03       Impact factor: 4.200

9.  Del-1 gene transfer induces cerebral angiogenesis in mice.

Authors:  Yongfeng Fan; Wei Zhu; Michael Yang; Yiqian Zhu; Fanxia Shen; Qi Hao; William L Young; Guo-Yuan Yang; Yongmei Chen
Journal:  Brain Res       Date:  2008-05-10       Impact factor: 3.252

10.  A DNA vaccine against extracellular domains 1-3 of flk-1 and its immune preventive and therapeutic effects against H22 tumor cell in vivo.

Authors:  Fan Lü; Zhao-Yin Qin; Wen-Bin Yang; Yin-Xin Qi; Yi-Min Li
Journal:  World J Gastroenterol       Date:  2004-07-15       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.